A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2369-2378

  Zhao, Fang Hui ^a   Tiggelaar, Sarah M ^a,b   Hu, Shang Ying ^a   Zhao, Na ^c   Hon, Ying ^d   Niyazi, Mayinuer ^e   Gao, Xiao Hong ^f   Ju, Li Rong ^g   Zhang, Li Qin ^h   Feng, Xiang Xian ⁱ   Duan, Xian Zhi ^j   Song, Xiu Ling ^k   Wang, Jing ^l   Yang, Yun ^m   Li, Chang Qin ⁿ   Liu, Jia Hua ^o   Liu, Ji Hong ^p   Lu, Yu Bo ^q   Li, Li ^r   Zhou, Qi ^s   Liu, Jin Feng ^t   Xu, Li Na ^u   Qiao, You Lin ^a   more..

^a CANCER HOSPITAL   (China)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Medical University   (China)

^d MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^e Xinjiang Uygur Autonomous Region Hospital   (China)

^f DALIAN MEDICAL UNIVERSITY   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h TIANJIN MEDICAL UNIVERSITY   (China)

ⁱ Shanxi Province Chang Zhi Medical University   (China)

^j CAPITAL MEDICAL UNIVERSITY   (China)

^k Feicheng People's Hospital in Shandong Province   (China)

^l HUNAN CANCER HOSPITAL   (China)

^m YICHUN UNIVERSITY   (China)

ⁿ Xinmi Maternal and Child Care Hospital   (China)

^o People's Hospital of Fujian Province   (China)

^p SUN YAT SEN UNIVERSITY   (China)

^q Yunnan Provincial Cancer Hospital   (China)

^r THIRD MILITARY MEDICAL UNIVERSITY   (China)

^s Cancer Hospital of Chongqing   (China)

^t Maternal and Children Hospital of Gansu Province   (China)

^u CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

more..

Author keywords

Cervical cancer; China; HPV vaccine; Human papillomavirus; Knowledge

Indexed keywords

WART VIRUS VACCINE;

ADMINISTRATIVE PERSONNEL; ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CHINA; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PROGNOSIS; QUESTIONNAIRE; STATISTICS; UTERINE CERVIX TUMOR; VACCINATION; VIROLOGY; WOMEN'S HEALTH;

ADMINISTRATIVE PERSONNEL; ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGNOSIS; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VACCINATION; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84872675611     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2369     Document Type: Article

References (23)

1. Brabin L, Roberts SA, Farzaneh F, Kitchener HC (2006). Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine, 24, 3087-94.
2. Brewer NT, Fazekas KI (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med, 45, 107-14.
3. Chen W, Zhang X, Molijn A, et al (2009). Human papillomavirus type-distribution in cervical cancer in China the importance of HPV 16 and 18. Cancer Causes Control, 20, 1705-13.
4. Dempsey AF, Davis MM (2006). Overcoming barriers to adherence to HPV vaccination recommendations. The Am J Manag Care, 12 (17 Suppl), S484-91.
5. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
6. Hopkins TG, Wood NJ, West RM, Darling JC (2009). UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health, 45, 652-5.
7. Koutsky LA, Ault KA, Wheeler CM, et al (2002). A controlled trial of a human papillomavirus type 16 vaccine. NEJM, 347, 1645-51.
8. Kwan TTC, Chan KKL, Yip AMW, et al (2008). Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong a qualitative-quantitative study. Sex Transm Infect, 84, 227-32.
9. Kwan TTC, Chan KKL, Yip AMW, et al (2009). Acceptability of human papillomavirus vaccination among Chinese women concerns and implications. BJOG, 116, 501-10.
10. Lee PWH, Kwan TTC, Fai K, et al (2007). Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med, 45, 130-4.
11. Li J, Li LK, Ma JF, et al (2009). Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine, 27, 1210-5.
12. Ministry of Health (2007). Ministry of Health (MOH) Chinese Health Statistics Yearbook (p. 337). Beijing, China: Peking Union Medical Press.
13. Muñoz N, Bosch FX, Sanjosé S de, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. NEJM, 348, 518-27.
14. Panatto D, Amicizia D, Lugarini J, et al (2009). Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies. Vaccine, 27 (Suppl 1), A6-10.
15. Rong S, Chen W, Wu L, et al (2002). [Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province]. Zhonghua Yu Fang Yi Xue Za Zhi, 36, 41-3.
16. Shi JF, Qiao YL, Smith JS, et al (2008). Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine, 26 (Suppl 1), M53-9.
17. Villa L, Costa R, Petta C, et al (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-8.
18. Walboomers JMM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
19. Woodhall SC, Lehtinen M, Verho T, et al (2007). Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. JAH, 40, 466-9.
20. Yang L, Parkin DM, Li L, Chen Y (2003). Time trends in cancer mortality in China: 1987-1999. Int J Cancer, 106, 771-83.
21. Zhang YZ, Ma JF, Zhao FH, et al (2010). Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas. Chin J Cancer, 29, 4-8 (in Chinese).
22. Zhao FH, Hu SY, Zhang SW, Chen WQ, Qiao YL (2010). Cervical cancer mortality in 2004-2005 and changes during last 30 years in China. Chin J Prev Med, 44, 408-12.
23. Zhao FH, Tiggelaar S, Hu SY, et al (2012). A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol, 36, 384-90.